Century Therapeutics, Inc. (IPSC) Net margin 2022–2025
Century Therapeutics, Inc. (IPSC) net profit margin by fiscal year — reported net income divided by reported revenue.
-8.8%FY2025 · since FY2022: -2518.4% → -8.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -8.8% | +1912.1 pp |
| FY2024 | -1920.9% | +4194.3 pp |
| FY2023 | -6115.1% | -3596.7 pp |
| FY2022 | -2518.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More IPSC financial trends
IPSC RevenueIPSC Net incomeIPSC Gross profitIPSC Gross marginIPSC Operating incomeIPSC Operating marginIPSC Operating cash flowIPSC Free cash flowIPSC Capital expendituresIPSC Return on equityIPSC Stock buybacksIPSC Dividends paidIPSC Total assetsIPSC Total liabilitiesIPSC Shareholders’ equityIPSC overview →